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June Supplement 20108S AbstractsMethods: All patients undergoing CAS for primary
carotid stenosis from 2003 to 2009 were reviewed. The
independent association of statins and perioperative mor-
bidity was assessed using multivariable analysis. Survival
curves and Cox regression models were used to assess late
morbidity and restenosis.
Results: A total of 1083 consecutive patients were
treated (29% females, mean age71.6y); 464 (43%) patients
were on statin medication before treatment. Statin use was
associated with a reduction of perioperative stroke and
death (HR 0.37; 95% CI 0.14-0.93; p 0.034) and major
stroke rate (HR 0.12; 95% CI 0.016-0.99%; p  0.049)
according to multivariable analysis. Statin effect was more
significant in reducing stroke and death in symptomatic
patients (HR 0.11; 95CI% 0.013-0.95; p  0.045). At 60
months survival (78% vs 82%; p  0.024) and stroke free
interval (p  0.042) rates were higher in statin group of
patients. Adjusting for demographics and comorbidities in
Cox regression analysis, statin use independently reduced
long-term mortality risk (HR 0.6; 95% CI 0.36-0.98; p 
0.043) and borderline decreased the risk of late stroke (HR
0.24; 95% CI 0.053 to 1.09; p 0.06). There was no effect
on restenosis rates.
Conclusions: These data suggest that statin use may
decrease both, perioperative and late stroke and mortality
rates in patients undergoing CAS. Statin therapy should be
considered part of the best medical treatment in current
CAS practice.
Author Disclosures: P. Cao: Nothing to disclose; V.
Caso: Nothing to disclose; E. Cieri: Nothing to disclose;
P. De Rango: Nothing to disclose; G. Isernia: Nothing to
disclose; G. Parlani: Nothing to disclose; F. Verzini:
Nothing to disclose.
SS9.
Long-term Results of Endovascular Treatment of Sub-
clavian and Innominate Arterial Stenosis
Ramesh Tripathi1, Billy Y. Cheung2, Kiriakos Ktenidis3.
1Indraprastha Apollo Hospital, New Delhi, India; 2Well-
ingtonHospital, Wellington, NewZealand; 3Aristotle Uni-
versity, Thessaloniki, Greece
Objectives: Obstructive lesions of the Brachiocephalic
and Subclavian arteries have been traditionally managed
using open surgery, but the advent of endovascular tech-
niques offers a new approach to the management of these
lesions. The aim of our study is to report clinical and
imaging results of a 10-year experience of the endovascular
management of these lesions with evaluation of end-points
at 3-year follow-up.
Methods: A retrospective review of a prospectively
collected data was undertaken of 112 patients (41 women;
mean age 58.9 years, range 36-84) who presented to our
institutions between 1997 and 2006 for endovascular treat-
ment of 141 innominate or subclavian arterial occlusive
lesions. End-points of the study were Primary Patency,Secondary Patency and Blood pressure differential in the
affected limb at 1, 2 and 3 years follow-up.
Results: Initial technical success was achieved in 134
(95.03%) lesions. Primary patency was 97.01% at 1 year,
91.7% at 2 years and 91.5 % at 3 years. Secondary patency
was 98.5% at 1 year, 97.7% at 2 years and 95.5% at 3 years.
A sustained nonrecurrence of symptoms and a BP differen-
tial improvement by 10 mm Hg was observed in 90%
cases at 3 years. Sub-analysis of data for stenotic lesions
revealed that Balloon Angioplasty performed as well as
Stenting. Stenting was superior to Balloon Angioplasty for
total occlusions. There was a complication rate of 7.8%
(2.84% major, 4.96% minor) with an attendant mortality
rate of 0.89%.
Conclusions: In our experience, endovascular inter-
ventions can be accomplished safely with a high degree of
technical success and excellent long-term clinical results
making it an attractive first line treatment for intrathoracic
supraaortic arterial occlusive disease. In addition, we advo-
cate primary stenting for all ostial lesions as well as total
occlusion in this setting.
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Objectives:To evaluate the safety and benefit of urgent
carotid endarterectomy (CEA) in patients with carotid
disease and acute stroke.
Methods: The study involved patients with acute mi-
nor and major strokes related to a carotid stenosis 50%
who underwent urgent CEA. Preoperative workup in-
cluded neurological assessment with National Institute of
Health Stroke Scale (NIHSS) on admission or immediately
before surgery and at discharge, carotid duplex scan, trans-
cranial Doppler ultrasound, head computed tomography
or magnetic resonance imaging. Endpoints were: perioper-
ative (30-day) neurological mortality, NIHSS score im-
provement or worsening (defined as a variation 4), hem-
orrhagic or ischemic stroke recurrence. Patients were
evaluated according to NIHSS score on admission (4-7 or
8), clinical and demographic characteristics, timing of
surgery ( or  6 hours), presence of brain infarction on
neuroimaging. p 0.05 was considered statistically signifi-
cant.
